• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?尿苷二磷酸葡萄糖醛酸基转移酶1(UGT1A1)启动子的种族变异性:胆红素代谢调节的一种平衡多态性?
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8170-4. doi: 10.1073/pnas.95.14.8170.
2
UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations.白种人和亚洲人中尿苷二磷酸葡萄糖醛酸基转移酶(UGT1A1*28和UGT1A6*2)基因多态性:与血清胆红素浓度的关系
Pharmacogenetics. 1999 Jun;9(3):341-9. doi: 10.1097/00008571-199906000-00009.
3
Bilirubin UDP-glucuronosyltransferase 1A1 (UGT1A1) gene promoter polymorphisms and HPRT, glycophorin A, and micronuclei mutant frequencies in human blood.胆红素UDP-葡萄糖醛酸基转移酶1A1(UGT1A1)基因启动子多态性与人血中次黄嘌呤磷酸核糖转移酶、血型糖蛋白A及微核突变频率
Mutat Res. 2004 May 9;560(1):1-10. doi: 10.1016/j.mrgentox.2004.01.010.
4
(TA)8 allele in the UGT1A1 gene promoter of a Caucasian with Gilbert's syndrome.一名患有吉尔伯特综合征的白种人UGT1A1基因启动子中的(TA)8等位基因。
Haematologica. 1999 Feb;84(2):106-9.
5
Bilirubin UDP-glucuronosyltransferase 1A1 gene polymorphisms: susceptibility to oxidative damage and cancer?胆红素UDP-葡萄糖醛酸基转移酶1A1基因多态性:对氧化损伤和癌症的易感性?
Mol Carcinog. 2000 Dec;29(4):198-204.
6
UGT1A1(TA)n promoter polymorphism--a new case of a (TA)8 allele in Caucasians.UGT1A1(TA)n启动子多态性——白种人中(TA)8等位基因的一个新病例。
Blood Cells Mol Dis. 2007 Mar-Apr;38(2):78-82. doi: 10.1016/j.bcmd.2006.10.160. Epub 2006 Dec 28.
7
Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism.UGT1A1启动子多态性对人肝组织中体外SN-38(伊立替康的活性代谢产物)与胆红素葡萄糖醛酸化的表型-基因型相关性研究
Clin Pharmacol Ther. 1999 May;65(5):576-82. doi: 10.1016/S0009-9236(99)70078-0.
8
Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups.不同种族中尿苷二磷酸葡萄糖醛酸基转移酶1A1启动子的单倍型结构
Pharmacogenetics. 2002 Dec;12(9):725-33. doi: 10.1097/00008571-200212000-00006.
9
Role of co-inherited Gilbert syndrome on hyperbilirubinemia in Indian beta thalassemia patients.共同遗传的吉尔伯特综合征在印度β地中海贫血患者高胆红素血症中的作用。
Hematology. 2014 Oct;19(7):388-92. doi: 10.1179/1607845413Y.0000000142. Epub 2013 Nov 30.
10
Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene.人类肝脏胆红素UDP-葡萄糖醛酸基转移酶活性与UGT1A1基因启动子区域多态性的关联。
J Hepatol. 2000 Sep;33(3):348-51. doi: 10.1016/s0168-8278(00)80268-8.

引用本文的文献

1
Association Between UGT1A1 mRNA Expression and Cis-Acting Genetic Variants and Trans-Acting Transcriptional Regulators in Human Liver Samples.人肝脏样本中UGT1A1 mRNA表达与顺式作用基因变异及反式作用转录调节因子之间的关联
Genes (Basel). 2025 Aug 18;16(8):971. doi: 10.3390/genes16080971.
2
Targeted drug monitoring in oncology for personalized treatment with use of next generation analytics.肿瘤学中的靶向药物监测,利用下一代分析技术实现个性化治疗。
Discov Oncol. 2025 Aug 11;16(1):1523. doi: 10.1007/s12672-025-03376-4.
3
Dose-Limiting Toxicities and the Maximum Tolerated Dose of Irinotecan Based on Genotypes: A Systematic Review.基于基因型的伊立替康的剂量限制性毒性和最大耐受剂量:一项系统评价。
Pharmaceutics. 2025 Apr 22;17(5):542. doi: 10.3390/pharmaceutics17050542.
4
Sexual dimorphism in metabolomic and phenotypic spectra of UGT deficiency: findings from the Canadian Longitudinal Study on Aging.尿苷二磷酸葡萄糖醛酸转移酶缺乏症代谢组学和表型谱中的性别二态性:来自加拿大衰老纵向研究的发现。
Biol Sex Differ. 2025 Apr 22;16(1):26. doi: 10.1186/s13293-025-00708-5.
5
Opportunities and Challenges of Population Pharmacogenomics.群体药物基因组学的机遇与挑战
Ann Hum Genet. 2025 Sep;89(5):384-397. doi: 10.1111/ahg.12596. Epub 2025 Apr 2.
6
Managing Irinotecan-Induced Diarrhea: A Comprehensive Review of Therapeutic Interventions in Cancer Treatment.管理伊立替康所致腹泻:癌症治疗中治疗干预措施的全面综述
Pharmaceuticals (Basel). 2025 Mar 2;18(3):359. doi: 10.3390/ph18030359.
7
Cancer Trial Eligibility and Therapy Modifications for Individuals With Duffy Null-Associated Neutrophil Count.杜菲阴性相关中性粒细胞计数个体的癌症试验资格和治疗方法修改。
JAMA Netw Open. 2024 Sep 3;7(9):e2432475. doi: 10.1001/jamanetworkopen.2024.32475.
8
Burden of rare genetic disorders in India: twenty-two years' experience of a tertiary centre.印度罕见遗传疾病的负担:一家三级中心的二十二年经验。
Orphanet J Rare Dis. 2024 Aug 13;19(1):295. doi: 10.1186/s13023-024-03300-z.
9
Combination of UGT1A1 polymorphism and baseline plasma bilirubin levels in predicting the risk of antipsychotic-induced dyslipidemia in schizophrenia patients.UGT1A1基因多态性与基线血浆胆红素水平联合预测精神分裂症患者抗精神病药物所致血脂异常的风险
Schizophrenia (Heidelb). 2024 May 17;10(1):52. doi: 10.1038/s41537-024-00473-1.
10
Next-generation sequencing based newborn screening and comparative analysis with MS/MS.基于下一代测序的新生儿筛查与 MS/MS 的比较分析。
BMC Pediatr. 2024 Apr 1;24(1):230. doi: 10.1186/s12887-024-04718-x.

本文引用的文献

1
Hemoglobin comparisons between African American and European American males with hemoglobin values in the normal range.血红蛋白值在正常范围内的非裔美国男性和欧裔美国男性之间的血红蛋白比较。
Am J Hum Biol. 1992;4(3):313-318. doi: 10.1002/ajhb.1310040306.
2
Studies on the neonatal development of the glucuronide conjugating system.葡萄糖醛酸结合系统的新生儿发育研究。
J Clin Invest. 1958 Mar;37(3):332-40. doi: 10.1172/JCI103613.
3
NADH-methemoglobin reductase (cytochrome b5 reductase) levels in two groups of American blacks and whites.两组美国黑人和白人中NADH-高铁血红蛋白还原酶(细胞色素b5还原酶)水平。
J Investig Med. 1998 Feb;46(2):82-6.
4
UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.UGT1启动子多态性导致遗传性球形红细胞增多症新生儿发病率增加。
Blood. 1998 Feb 1;91(3):1093.
5
Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.导致家族性非溶血性未结合胆红素血症的尿苷二磷酸葡萄糖醛酸基转移酶-1(UGT1)基因的遗传缺陷。
Clin Chim Acta. 1997 Oct 9;266(1):63-74. doi: 10.1016/s0009-8981(97)00167-8.
6
The expression of uridine diphosphate glucuronosyltransferase gene is a major determinant of bilirubin level in heterozygous beta-thalassaemia and in glucose-6-phosphate dehydrogenase deficiency.尿苷二磷酸葡萄糖醛酸基转移酶基因的表达是杂合子β地中海贫血和葡萄糖-6-磷酸脱氢酶缺乏症中胆红素水平的主要决定因素。
Br J Haematol. 1997 Nov;99(2):437-9. doi: 10.1046/j.1365-2141.1997.4113228.x.
7
Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome.杂合子β地中海贫血中的高胆红素血症与共同遗传的吉尔伯特综合征有关。
Br J Haematol. 1997 Nov;99(2):433-6. doi: 10.1046/j.1365-2141.1997.3703182.x.
8
Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.吉尔伯特综合征与葡萄糖-6-磷酸脱氢酶缺乏症:对新生儿高胆红素血症至关重要的剂量依赖性基因相互作用。
Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):12128-32. doi: 10.1073/pnas.94.22.12128.
9
The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.UDP糖基转移酶基因超家族:基于进化差异的推荐命名更新
Pharmacogenetics. 1997 Aug;7(4):255-69. doi: 10.1097/00008571-199708000-00001.
10
Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults.儿童和青年血清胆红素分布及其与心血管风险的关系。
Atherosclerosis. 1997 May;131(1):107-13. doi: 10.1016/s0021-9150(97)06088-7.

尿苷二磷酸葡萄糖醛酸基转移酶1(UGT1A1)启动子的种族变异性:胆红素代谢调节的一种平衡多态性?

Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

作者信息

Beutler E, Gelbart T, Demina A

机构信息

The Scripps Research Institute, Department of Molecular and Experimental Medicine, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.

出版信息

Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8170-4. doi: 10.1073/pnas.95.14.8170.

DOI:10.1073/pnas.95.14.8170
PMID:9653159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC20948/
Abstract

A polymorphism in the promoter of the UDP-glucuronosyltransferase 1 (UGT1A1) gene has been shown to cause Gilbert syndrome, a benign form of unconjugated bilirubinemia. Promoters containing seven thymine adenine (ta) repeats have been found to be less active than the wild-type six repeats, and the serum bilirubin levels of persons homozygous or even heterozygous for seven repeats have been found to be higher than those with the wild-type six repeats. We have now examined the genotypes in persons of Asian, African, and Caucasian ancestry. Although within the Caucasian ethnic group there is a strong correlation between promoter repeat number and bilirubin level, between ethnic groups we found that this relationship to be inverse. Among people of African ancestry there are, in addition to those with six and seven repeats, also persons who have five or eight repeats. Using a reporter gene we show that there is an inverse relationship between the number of ta repeats and the activity of the promoter through the range of 5-8 ta repeats. An incidental finding was a polymorphism at nucleotide -106, tightly linked to the (ta)5 haplotype. Serum bilirubin levels are influenced by many factors, both genetic and environmental. We suggest that the unstable UGT1A1 polymorphism may serve to "fine-tune" the plasma bilirubin level within population groups, maintaining it at a high enough level to provide protection against oxidative damage, but at a level that is sufficiently low to prevent kernicterus in infants.

摘要

尿苷二磷酸葡萄糖醛酸基转移酶1(UGT1A1)基因启动子的多态性已被证明会导致吉尔伯特综合征,这是一种非结合胆红素血症的良性形式。已发现含有七个胸腺嘧啶腺嘌呤(ta)重复序列的启动子活性低于野生型的六个重复序列,并且已发现七个重复序列的纯合子甚至杂合子个体的血清胆红素水平高于具有野生型六个重复序列的个体。我们现在研究了亚洲、非洲和高加索血统人群的基因型。虽然在高加索种族群体中,启动子重复序列数量与胆红素水平之间存在很强的相关性,但在不同种族群体之间,我们发现这种关系是相反的。在非洲血统的人群中,除了有六个和七个重复序列的个体外,还有五个或八个重复序列的个体。使用报告基因,我们发现在5 - 8个ta重复序列范围内,ta重复序列的数量与启动子活性之间存在反比关系。一个偶然的发现是在核苷酸 -106处存在多态性,它与(ta)5单倍型紧密连锁。血清胆红素水平受遗传和环境等多种因素影响。我们认为,不稳定的UGT1A1多态性可能有助于在人群组内“微调”血浆胆红素水平,将其维持在足够高的水平以提供抗氧化损伤的保护,但又保持在足够低的水平以防止婴儿发生核黄疸。